# The Safety of Boostrix Following Routine Immunization of Pregnant Women

> **NCT03463577** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 65783 (actual)

## Conditions studied

- Whooping Cough

## Interventions

- **OTHER:** Safety assessment following routine immunization with Boostrix

## Key facts

- **NCT ID:** NCT03463577
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-13
- **Primary completion:** 2020-08-04
- **Final completion:** 2020-08-04
- **Target enrollment:** 65783 (ACTUAL)
- **Last updated:** 2022-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03463577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03463577, "The Safety of Boostrix Following Routine Immunization of Pregnant Women". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03463577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*